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Summary
CD1 molecules consist of R2-microglobulin (R2m) noncovalently complexed to a non-major
histocompatibility complex (MHC)-encoded monomorphic integral membrane protein ho-
mologous to MHC class I ot chains. Little is known about the requirements for cell surface ex-
pression and T cell recognition of CD1 . We inserted the mouse CD1 .1 gene into vaccinia vi-
rus to create a recombinant virus expressing CD 1 .1 under the control of a viral promoter.
Using this recombinant virus to infect normal or mutant cell lines, we found that the expres-
sion ofmolecules reactive with the CD1 .1-specific monoclonal antibody 3C11 requires the ex-
pression of R,m but was not affected by the absence of the MHC-encoded peptide transporter
(TAP) . Consistent with these results, IL-2 production by the mCD1 .1-specific T cell hybrid-
oma DN32.D3 was induced by thymocytes from normal mice or mice with a homozygous de-
letion of the TAP1 gene, but not by thymocytes from mice with a homozygous deletion ofthe
(32m gene. These results indicate that expression of functional mCD1 .1 occurs in a R2m-depen-
dent, TAP-independent manner.
M
HC class la molecules consist of a highly polymor-
phic integral membrane protein (ac chain) nonco-
valently associated with R2-microglobulin ((3201 to form a
binding site that carries peptides to the cell surface for sur-
veillance by CD8+ T cells (TCD8+) . Most class I-associated
peptides derive from a cytosolic pool of proteins through
the action of cytosolic and/or nuclear proteases (1, 2) . Pep-
tides associate with newly synthesized class I molecules in
an early secretory compartment, probably the endoplasmic
reticulum (ER) (3). Cytosolic/nuclear peptides reach the
ER through the action of a membrane transporter known
as TAP, which is formed by association of the products of
TAP1 and TAP2 genes located within the MHC. After
their assembly, a-R2m complexes associate with TAP via
the TAP1 subunit until released upon peptide binding. The
heterotrimeric complex is then transported through the
Golgi complex to the cell surface. In the absence of TAP,
class I molecules are exported from the ER, but slowly and
in a form that is rapidly denatured once they reach the
plasma membrane (4-9) . Class la molecules are constitu-
tively expressed in many body tissues and can be expressed
in most others after exposure of cells to the appropriate cy-
'Abbreviations used in this paper: 02m, (32-nucroglobulin; BFA, brefeldin A;
ER, endoplasmic reticulum; MOI, multiplicity ofinfection; rVV, recom-
binant vaccinia virus; Tcns+, CD8+ T cells.
tokines. This is consistent with the primary function of
class la molecules in the presentation of peptides from in-
tracellular pathogens to the immune system.
A number of molecules highly similar to class la mole-
cules are encoded by the mammalian MHC . These mole-
cules, variously termed class Ib molecules, medial histo-
compatibility molecules, or nonclassical class I molecules,
are structurally highly similar to class I molecules in consist-
ing of an ot chain noncovalently complexed to R,m. Unlike
class la molecules, class Ib molecules display little, if any,
polymorphism and have a highly restricted tissue distribu-
tion. Some class Ib molecules have been directly demon-
strated to bind short peptides (10-15) and present them to
T cells (10-13, 16-18) . Some class Ib molecules acquire
peptides in a TAP-dependent manner (19-21) ; others ap-
pear to procure peptides independently of TAP (19, 22) .
Mammals also express non-MHC-encoded class I-like
molecules. These exhibit less homology to class la mole-
cules than the MHC-encoded class Ib molecules, and, in
the case of the neonatal Fc receptor, the known function is
completely unrelated to T cells (23-25). The CD1 family
of class Ib molecules, on the other hand, is involved in T
cell function. CD1 molecules are expressed by virtually all
mammals examined (26). Five human CD1 genes have
been identified (hCD1a-e). hCDla-c, and -e are more ho-
mologous to each other than CDld (27). hCDla-c, which
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GM-CSF-treated monocytes, can be recognized by T cells
expressing either the ct/p or ,y/8 T cell receptors (28-30).
Most remarkably, it was recently demonstrated that one of
these T cells apparently recognizes mycobacterial lipid pre-
sented by hCDlb (31).
Two CD1 genes have been identified in mice, mCD1 .1
and mCD1 .2. Both are predominantly expressed in the gut
and on cortical thymocytes (32-34), and both are homolo-
gous to hCDld, whose expression is largely limited to the
gut. We recently demonstrated that mCD1 .1 is recognized
by a subset of NK1.1 + T cells expressing an invariant Vot T
cell receptor chain with VP chains of limited variability
(35). This extended prior findings that a humanjejunal in-
traepithelial T cell line could lyse hCD1d-transfected target
cells (36) . In the present study we examine the require-
ments for (32m and TAP in the surface expression of
mCD1 .1 as detected by the CD1-specific mAb 3C11 (32)
or the CD1-specific NK1.1+ T cell-derived hybridoma
DN32.D3.
Materials and Methods
Mice.
￿
C57BL/6 mice were purchased from Taconic Farms,
Inc. (Germantown, NY). C57BL/6 mice with a homozygous
disruption of the R2m gene were obtained from TheJackson Lab-
oratory (Bar Harbor, ME). (B6 X 129)Fl mice with a homozy-
gous disruption of the TAP1 gene (37) were kindly provided by
Dr. L. Van Kaer (Vanderbilt University, Nashville, TN). Control
(B6 X 129)Fl mice were kindly provided by Dr. P. Love (Na-
tional Institute of Child Health and Human Development, Be-
thesda, MD). Mice ranged in age from 7 wk to 7 mo.
Cell Lines. MC57G, a fibroblast cell line derived from
C57BL (H-26) mice and TK-p54, a human osteosarcoma cell
line, were grown in DME (GIBCO BRL, Gaithersburg, MD),
supplemented with 7.5% heat-inactivated fetal bovine serum
(Biofluids, Inc., Rockville, MD), Na2CO3, and r,-glutamine. The
human lymphoblastoid cell line T2, which contains a deletion
encompassing the MHC class II region, including the genes en-
coding the TAP subunits (38, 39), was provided by Dr. P. Cress-
well (Yale University, New Haven, CT) and was propagated in
Iscove's medium (GIBCO BRL) with the same supplements as
above. The human [32m-deficient SS melanoma cell line (pro-
vided by Dr. N. Restifo, National Cancer Institute, Bethesda,
MD) was grown in RPMI 1640 medium (Biofluids, Inc.) with
the same additives as with DMEM above. FO-1 cells, a human
[3,m-deficient melanoma (40) (provided by Dr. S. Ferrone, New
York Medical College, Valhalla, NY) were maintained in DME
as above. The murine IL-2-dependent cell line CTLL-2 was
provided by Dr. E. W. Shores (Food and Drug Administration,
Bethesda, MD).
Recombinant Vaccinia Virus (rVV) Generation.
￿
cDNA encoding
mCD1.1 in Bluescript (Stratagene Inc., La Jolla, CA) (provided
by Dr. S. Balk, Beth Israel Hospital, Boston, MA) was excised us-
ing Xhol and BamHI. The fragment was then inserted into the
Sall/BgIlI sites ofpSC11 modified by addition o£amultiple clon-
ing site downstream of the vaccinia virus p7.5 promoter. The
generation ofan rVV encoding mCD1 .1 (VV-mCD1 .1) was per-
formed using standard techniques as previously reported (41) .
rVV coexpressing TAP1 and TAP2 genes (VV-Tap[1+2]), or
expressing H-2 K6 (VV-Kb), Kd (VV-Kd), or human [32m (VV_
1914
￿
TAP-independent Expression ofmCD1.1
hN have been described (42, 43). In all experiments, cells were
infected with the rVV at a multiplicity of infection (MOI) of 10
for the indicated lengths oftime.
Thermostability Analysis.
￿
T2 cells (5 X 106) infected overnight
with rVV- at 26°C were washed and plated in 96-well U-bottom
plates (Costar Corp., Cambridge, MA) at 105 cells per well. To
one-halfof theplates, brefeldin A (BFA; Sigma Chemical Co., St.
Louis, MO) was added at a final concentration of5 Wg/ml. Plates
were then incubated at 26°C or 37°Cfor3 h, and indirect immu-
nofluorescence was performed as described below.
Antibodies and Cytofluorography. The following mAbs were
purchased from American Type Culture Collection (ATCC,
Rockville, MD): W6/32 (44) (ATCC No. HB-95), panreactive
anti-HLA; BBMA (45) (ATCC No. HB-28), anti-human R2m;
SF1.1 .1 (ATCC No. HB-159), anti-H-2Kd; and Y3 (46) (ATCC
No. HB-176), anti-H-2K6. 3C11 (32) (anti-mCD1 .1, rat IgM)
was provided by Drs. C. Terhorst (Beth Israel Hospital) and R.
Blumberg (Brigham and Women's Hospital, Boston, MA). Fluo-
rescein-labeled rabbit anti-mouse Ig antiserum was purchased
from Dako Corp. (Carpenteria, CA). PE-conjugated goat anti-rat
chain antiserum was obtained from Southern Biotechnology
Associates (Birmingham, AL). Staining ofuninfected and rVV-in-
fected cells was performed as previously described (47, 48) and
was quantitated using a FACScan© cytofluorograph (Becton
Dickinson & Co., Mountain View, CA). Ethidium homodimer
(Molecular Probes, Inc., Eugene, OR) was added to the cells at a
final concentration of 10 Rg/ml immediately before analysis;
ethidium-stained, presumably nonviable cells were excluded from
analysis.
Hybridoma Assay.
￿
Thymocytes (5 X 105 cells per well) were
cultured with or without the mCD1 .1-specific hybridoma
DN32.D3 (49) (3 X 104 cells per well) in flat-bottom microtiter
plates (Costar Corp.) as described previously (35). 20 h later the
plates were centrifuged, and the supernatants were assayed for
IL-2 using the rnurine IL-2-dependent cell line CTLL-2 as pre-
viously described (35).
Results and Discussion
To conveniently study the expression and function of
mCD1 .1 in a variety of cells lines (and for use in future in
vivo studies), we inserted a cDNA encoding mCD1 .1 into
VV under the control of the p7.5 VV promoter (42) . The
expression of mCD1 .1 on the surface of viable cells was
monitored using the 3C11 mAb (32) . This mAb is likely to
react with native mCD1 .1, since it blocks recognition by
mCD1 .1-specific T cells (35) . After infection of MC57G
mouse fibroblast cells with VV-mCD1.1, CD1.1 expres-
sion on the surface ofviable cells was detected by the CD1-
specific 3Cll mAb via indirect immunofluorescence and
cytofluorography as early as 3 h after infection, reaching
near-maximal levels 3 h later (Fig. 1) . By contrast, cells in-
fected with a control rVV were not stained above back-
ground levels observed using uninfected cells, thus demon-
strating the specificity of staining for CD1.1 . CD1.1
expression at the cell surface reflects its biosynthesis by in-
fected cells and not simply adsorption onto the cell surface
from the virus inoculum (which consists of a crude lysate
from infected cells) since infection of cells in the presence
ofthe protein synthesis inhibitorcycloheximide completely
blocked CD 1.1 cell surface expression (data not shown) .A
Figure 1 . Characterization ofmCD1 .1 cell surface expression . (A) Mu-
rine MC57G fibroblasts (H-2 6) were either mock infected or infected
with VV-mCD1 .1 at an MOI of 10 for the indicated number of hours at
37 °C . The cells were then tested for the expression ofmCD1 .1 by stain-
ing with the anti-mCD1 .1 mAb 3C11, followed by an FITC-conjugated
rabbit anti-mouse antiserum . Analysis of viable cells was by FACScano .
The percentage ofpositive cells and median channel fluorescence ofposi-
tive cells are indicated . (B) T2 cells were infected with VV-mCD1 .1 or
VV-Kb (control) at an MOI of 10 overnight at 26°C . The cells either re-
mained at 26 °C or were incubated at 37°C for 3 h more in the presence
of 5 Wg/ml BFA . The cells were then stained with 3C I I (mCD l . l) or
Y3 (H-2Kb), followed by an FITC-conjugated rabbit anti-mouse Ig anti-
serum . Analysis ofviable cells was by FACScan° . In both A and B, the
x- and y-axes correspond, respectively, to the fluorescence intensity and
the number ofcells .
Both human and murine CD1 molecules associate with
R2m (32, 50, 51) . It has been reported, however, that co-
biosynthesis of (32m is not required for the expression of
mouse or human CD1 on the surface of R2m-deficient
FO-1 human melanoma cells transfected with the respec-
tive genes (52) . To explore this issue, we infected a R2m-
deficient human melanoma cell line (SS) with VV-
mCD1.1 with or without an rVV expressing human (32m
(VV-hP2) . SS cells express virtually no cell surface class I
molecules reactive with the W6/32 mAb, which binds
only native class I molecules . Infection with VV-hP2
greatly increases expression of W6/32-reactive cell surface
HLA molecules (Table 1, experiment 1) . Infection of cells
with VV-mCD1 .1 or an rVV expressing the mouse H-2Kd
class la a chain resulted in marginally detectable levels of
mCD1.1 or Kd . Coinfection with VV-hP2 greatly in-
creased the surface expression of both mCD1.1 and Kd
(Table 1, experiment 1) .
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These data demonstrate that the expression of 3C11-
reactive mCD1.1 on the surface of VV-mCD1 .1-infected
cells is greatly enhanced by coexpression of (32m, although
we cannot rule out the possibility that free mCD1 .1 heavy
chains are present on the surface of (32m-deficient cells and
are undetectable by 3C11 . This finding appears to conflict
with the conclusion of Balk et al . that mCD1 .1 expression
on FO-1 cells transfected with mCD1 .1 is independent of
R2m (52) . To explore this discrepancy, we obtained FO-1
cells and performed a similar experiment . As seen in Table
1 (experiment 2), FO-1 cells expressed greater amounts
ofCD1 .1 than SS cells, and again only very small amounts
of 3C11-reactive material were expressed in the absence of
¢2m, whose expression enhanced 3C 11 staining -50-fold
(after subtracting background staining) . This is likely to be
an underestimation of the effect of (32m, since mCD1 .1
biosynthesis will be compromised to some extent because
of competition from VV-hP2 for gene expression . Since
Table 1 .
￿
Cell Surface Expression ofmCD1.1 Requires
Endogenous (B 2m
Cells infected with
Mean channel fluorescence
mCD1 .1 human (3,m HLA H-2K d
SS and FO-1 cells were infected with the indicated rVV at an MOI of
10 for either 5 .5 (experiment 1) or 12 .5 h (experiment 2) at 37 °C . The
cells were then stained for mCDI .l, human (32m, human HLA, or
H-2K11 expression, using 3C11, BBM .1, W6/32, and SFl-1 .1 .1 mAb,
respectively, followed by an FITC-conjugated rabbit anti-mouse Ig an-
tiserum . In experiment 2, 3C11 was followed by a PE-labeled goat
anti-rat W chain antiserum . Analysis was by FACScan® .
Experiment 1
SS
Mock 0 1 2 1
VV-WR2m 0 145 153 0
VV-mCD1 .1 1 7 6 0
VV-mCD1 .1
VV-WR2m 56 150 128 2
VV-Kd 0 3 3 2
VV-Kd + VV-WR2m 0 184 197 102
Experiment 2
SS
Mock 0 2 2
VV-WR2rri 1 82 78
VV-mCD1 .1 2 6 5
VV-mCD1 .1
VV-WR2m 82 94 60
FO-1
Mock 2 1 1
VV-WR2m 3 121 140
VV-mCD1 .1 9 13 9
VV-mCD1 .1
VV-WR2m 245 94 55Balk et al. did not examine the effect of coexpression of
mCD1 .1 with R2m in FO-1 cells, it is possible that the
amount of mCD1 .1 they detected on cells transfected with
the mCD1 .1 gene corresponds to the very low levels of
mCDl .1 we detect on the surface of cells not coinfected
with VV-hP2. An additional complexity is that Balk et al.
used a different mAb to detect mCD1. Since this mAb may
be better able to detect unfolded CD1 .1 than 3Cll, our
findings do not eliminate the possibility that mCD1 is
transported to the cell surface in (32m-deficient cells. As
demonstrated below, however, [32m is clearly required for
expression ofat least one form ofmCD 1 .1 recognized by T
cells. Whether or not [32m would have a similar effect on
the cell surface expression ofhCDld in FO-1 cells remains
a question.
We next examined the requirement for TAP in the sur-
face expression of3C11-reactive CD1 .1 molecules. Class la
molecules expressed on the surface of TAP-deficient cells
at 26°C lose reactivity with mAbs reactive with native mol-
ecules when cells are shifted to 37°C, because o£ the ab-
sence of high-affinity peptides needed to stabilize class I
molecules. T2 cells, which lack a megabase region of the
MHC encoding TAP, were infected for 18 h at 26°C with
VV-Kb or VV-mCD1 .1 and incubated for an additional 3 h
in the presence ofBFA at 37°C or 26°C before surface ex-
pression of class I molecules was determined by indirect
immunofluorescence using either 3C11 or the Y3 mAb
specific for native Kb. BFA was included to minimize the
exocytosis of additional intracellular class I molecules (53,
54). As expected, Kb expression was greatly diminished by
the shift in temperature to 37°C (Fig. 1 B). By contrast,
CD1 .1 expression was unaffected by this shift. This dem-
onstrates, first, the thermostability of CD 1 .1 protein at the
cell surface, and second, that CD1 .1 is not detectably inter-
nalized or shed over the 3-h incubation period.
We further examined the effect of TAP expression of
CD1 .1 cell surface expression by coinfecting, T2 cells for 18 h
at 37°C with VV-mCD1.1 and an rVV expressing human
TAP1 and TAP2 (VV-TAP[1+2]) . As shown in Table 2
(and reported previously in reference 54a), VV-TAP[1+2]
infection increased the expression of endogenous HLA
Table 2.
￿
Surface Expression of mCD1.1 Is TAPIndependent
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class molecules reactive with the W6/32 mAb. Similarly,
cells coinfected with VV-CD1 .1 and VV-TAP[1+2] dem-
onstrated an increase in HLA expression. Despite the coex-
pression of TAP, CD1 .1 expression actually decreased rela-
tive to cells infected only with VV-CD1 .1 (additional
experiments show that the decrease is attributable to inter-
recombinant competition for gene expression).
We previously reported that murine NK1.1 + T cells,
which express an invariant T cell receptor ot chain, specifi-
cally recognize mCD1 .1, as demonstrated using cells in-
fected with VV-CD1.1 (35). To examine the effects of
[32m and TAP expression on T cell recognition of
mCD1 .1, we examined the ability of the NK1 .1 + T cell-
derived mCD1 .1-specific T cell hybridoma DN32 .D3 (35,
49) to release IL-2 in response to a 20-h coincubation with
thymocytes derived from normal mice or mice with ho-
mozyogous deletions in genes encoding [32m or TAP1 . As
shown in Table 3, IL-2 production by the DN32.D3
mCD1 .1-specific T cell hybridoma was induced by normal
C57BL/6 thymocytes, as we have previously reported (35).
Thymocytes from wild-type (B6 X 129)F, mice were also
able to induce the production of IL-2 by DN32.D3 cells
(these mice were used as a control for the TAP1-deficient
mice, which were only available on this background) . As
we have reported previously (35), thymocytes from RZm-
deficient mice were unable to stimulate IL-2 production by
DN32.D3 cells. By contrast, thymocytes from mice lacking
TAP1 stimulated IL-2 release to an extent similar to
thymocytes derived from C57BL/6 or (B6 X 129)Fl
thymocytes (Table 3) . Consistent with this finding, thy-
mocytes derived from the TAP1-deficient mice bound
similar amounts of the 3C11 mAb as thymocytes derived
from normal mice (not shown).
Taken together, these findings demonstrate that both the
surface expression of mCD1.1 and recognition by T cells
occur mostly in a RZm-dependent, TAP-independent man-
ner. The TAP independence of mCD1.1 is similar to find-
ings made with hCDlb, which was shown to present a
mycobacterial lipid in a TAP-independent manner (31) .
The nature of the ligands presented by mCD1 .1, or, in-
deed, whether mCD1 .1 presents a ligand at all, remains to
Mean Channel Fluorescence
*T2 cells were either mock infected or infected with VV-mCDt.1, VV-TAP[1 + 2],or both, overnight at 37°C. The cells were then stained with
antibodies against mCD1 .1 (3C11) or HLA (W6/32), followed by an FITC-conjugated rabbit anti-mouse Ig antiserum. Analysis was by FACScan®.
T2 Cells infected with*
Experiment 1
Anti-mCDI A Anti-HLA
Experiment 2
Anti-mCD1.1 Anti-HLA
Mock 0 899 1 772
VV-mCD1 .1 56 833 84 692
VV-mCD1 .1 + VV-TAP[1 + 2] 52 1222 65 1275
VV-TAP[1 + 2] 2 1326 0 1674Table 3 .
￿
Recognition of mCD1 .1 by them CD1 .1-specific T Cell Hybridoma, DN32.D3, is TAP Independent
be determined. Assuming that the NK1.1+ cells are the
major immune cell population that interacts with mCD1 .1,
the invariant nature oftheir TCR suggests that they recog-
nize mCD1 .1 bound either to a highly conserved ligand or
to no ligand at all. In the latter case, mCD1.1 would be
acting strictly as a regulator of immune responses, which is
consistent with the prodigious ability ofNK1.1+ T cells to
secrete IL-4 (55-57). In the former case, the conserved
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